A novel mutation of the RP1 gene (Lys778ter) associated with autosomal dominant retinitis pigmentosa
- 1Molekulargenetisches Labor, Universitäts-Augenklinik, Auf der Morgenstelle 15, 72076 Tübingen, Germany
- 2Universitäts-Augenklinik Abt II, Schleichstrasse 12–16, 72076 Tübingen, Germany
- Correspondence to: Eckart Apfelstedt-Sylla, Universitäts-Augenklinik Abt. II, Schleichstr. 12–16, 72076 Tübingen, Germany
- Accepted 16 August 2001
Abstract
Background: Besides the three known genes (RHO, RDS/Peripherin, NRL) involved in autosomal dominant retinitis pigmentosa (adRP), a fourth gene, RP1, has been recently identified. Initial reports suggest that mutations in the RP1 gene are the second most frequent cause of adRP. The clinical findings were described in a family with adRP and a novel mutation in the RP1 gene.
Method: Index patients from 15 independent families with adRP in which RHO mutations had been excluded in previous examinations were screened for mutations in the RP1 gene by means of direct DNA sequencing. Evaluation of the RP1 phenotype in patients included funduscopy, kinetic perimetry, dark adapted final threshold test, standard electroretinography and, in one case, multifocal electroretinography.
Results: One novel nonsense mutation (Lys778ter) in one of these 15 patients was detected. Cosegregation of the mutation with the disease phenotype could be established in the index patient's family. The phenotype comprises variable expression of clinical disease probably including one case of incomplete penetrance, a onset of symptoms beginning in adulthood, and evidence of regionally varying retinal function loss.
Conclusion: The Lys778ter mutation localises inside the critical region harbouring all mutations described so far. The ophthalmic findings support previous observations that variation of disease expression appears as a typical feature of the RP1 phenotype.
